JAKAVI (Ruxolitinib) 5MG x 30 Tablets

JAKAVI (Ruxolitinib) is a prescription medication used to treat certain conditions related to the immune system, specifically for patients with myelofibrosis and polycythemia vera. It works by inhibiting specific enzymes that play a crucial role in the signaling pathways of the immune system, helping to reduce symptoms and improve quality of life.

Indications

JAKAVI is indicated for the treatment of:

• Myelofibrosis
• Polycythemia vera

How It Works

Ruxolitinib is a Janus kinase (JAK) inhibitor that selectively inhibits JAK1 and JAK2 enzymes, which are involved in the signaling of various hematopoietic and immune system processes. By blocking these enzymes, JAKAVI helps to decrease inflammation and reduce the overproduction of blood cells.

Dosage and Administration

The recommended dosage of JAKAVI may vary based on the specific condition being treated and the patient's individual response. It is crucial to follow the prescribing physician's instructions regarding dosage and administration.

Possible Side Effects

Like all medications, JAKAVI may cause side effects. Common side effects include:

• Headache
• Nausea
• Fatigue
• Diarrhea

Patients should report any severe or persistent side effects to their healthcare provider.

Precautions

Before starting treatment with JAKAVI, inform your healthcare provider about any existing medical conditions, particularly:

• Infections
• Liver problems
• Blood disorders

Regular monitoring may be required during treatment.

Consult Your Doctor

It is essential to consult your healthcare provider for personalized medical advice and to discuss any potential interactions with other medications you may be taking.